Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
Marcus Flather(Norfolk and Norwich University Hospital), Eugene Braunwald(Mass General Brigham), Marc A. Pfeffer(Brigham and Women's Hospital), Lars Køber(University of Copenhagen), Gordon Murray(Nova Scotia Department of Agriculture), Stephen G. Ball(Curtin University), Christian Torp‐Pedersen(University of Copenhagen), Lemuel A. Moyé(University of Houston), Janice Pogue(McMaster University), Alistair S. Hall(British Heart Foundation), Salim Yusuf(Population Health Research Institute)
Cited by 1,593
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k